Honokiol: A potent chemotherapy candidate for human colorectal carcinoma

doi:10.3748/wjg.v10.i23.3459

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4591)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

397

HTML

3822

Figures (1-8)

216

Tables (1-3)

156

Sum=4591

Dec 1, 2004 (publication date) through Aug 30, 2024

Times Cited of This Article

Times Cited (103)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Dec 1, 2004; 10(23): 3459-3463
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3459

Table 3 Effect of honokiol on MST and T/C% in Balb/c nude mice bearing RKO-incubated tumor

Group	Number of mice	MST (d)	T/c (%)
Control	7	28.8	100
Vehicle	6	29.7	104.5
Adriamycin	7	46.2^a	160.4^b
Honokiol	7	50.9^a	176.7^b

MST, mean survival time. The survival rate (T/C%) was cal-culated according to the following equation: T/C (%) = [average survival period in the test group/average survival period in the control group] × 100.

^aP < 0.05;

^bP < 0.01 vs vehicle or control.

Citation: Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463
URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3459.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3459